glp 1 agonists for type 2 diabetes GLP-1 receptor individualized treatment of mellitus GLP1 Receptor Agonists vs SGLT2-I

Y., Kim, Y

The multidisciplinary team of GI providers, gut-brain specialists, and registered dietitians at Oshi Health can offer a tailored treatment plan to help you implement the lifestyle and behavioral adjustments needed to reduce GI side effects associated with GLP-1 drugs

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): A double-blind, randomised, phase 3 trial

Here is a professional breakdown of how to choose the right path with your healthcare provider

Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis

Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists